オピオイド誘発性便秘(OIC):グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Opioid-Induced Constipation (OIC) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Opioid-Induced Constipation (OIC) to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Opioid-Induced Constipation (OIC) to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Opioid-Induced Constipation (OIC) 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Opioid-Induced Constipation (OIC) 33
Oct 31, 2013: Synergy Pharmaceuticals Initiates Phase 2 Study of SP-333 in Patients with Opioid-Induced Constipation 33
Oct 14, 2013: AstraZeneca Announces New Safety Data For Naloxegol In Patients with Opioid-Induced Constipation 33
Oct 02, 2013: Synergy Pharmaceuticals Announces Plans to Initiate a Phase 2 Study of SP-333 for Opioid-Induced Constipation 34
Jul 18, 2013: Cubist Enrolls First Patient in Phase 3 Efficacy Studies Evaluating Bevenopran for the Treatment of Opioid-Induced Constipation 34
Feb 26, 2013: AstraZeneca Announces Results From Long-term Safety Trial Of Naloxegol In Patients With Opioid-induced Constipation 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Salix Pharmaceuticals Ltd. 36
Clinical Trial Overview of Salix Pharmaceuticals Ltd. 36
AstraZeneca PLC 38
Clinical Trial Overview of AstraZeneca PLC 38
Mundipharma International Limited 40
Clinical Trial Overview of Mundipharma International Limited 40
Shionogi & Co., Ltd. 41
Clinical Trial Overview of Shionogi & Co., Ltd. 41
Cubist Pharmaceuticals, Inc. 42
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 42
Theravance, Inc. 43
Clinical Trial Overview of Theravance, Inc. 43
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
Novartis AG 45
Clinical Trial Overview of Novartis AG 45
Alkermes Plc 46
Clinical Trial Overview of Alkermes Plc 46
Alkermes Inc. (Inactive) 47
Clinical Trial Overview of Alkermes Inc. (Inactive) 47
Clinical Trial Overview of Top Institutes / Government 48
Friedrich-Schiller-Universitat Jena 48
Clinical Trial Overview of Friedrich-Schiller-Universitat Jena 48
The University of Vermont 49
Clinical Trial Overview of The University of Vermont 49
St. John’s Health System 50
Clinical Trial Overview of St. John’s Health System 50
VU University Medical Center 51
Clinical Trial Overview of VU University Medical Center 51
Shriners Hospitals for Children 52
Clinical Trial Overview of Shriners Hospitals for Children 52
Kuopio University Hospital 53
Clinical Trial Overview of Kuopio University Hospital 53
British Columbia Cancer Agency 54
Clinical Trial Overview of British Columbia Cancer Agency 54
UMC Utrecht Holding BV 55
Clinical Trial Overview of UMC Utrecht Holding BV 55
Ullevaal University Hospital 56
Clinical Trial Overview of Ullevaal University Hospital 56
Five Key Clinical Profiles 57
Appendix 138
Abbreviations 138
Definitions 138
Research Methodology 139
Secondary Research 139
About GlobalData 140
Contact Us 140
Disclaimer 140
Source 141


【レポート販売概要】

■ タイトル:オピオイド誘発性便秘(OIC):グローバル臨床試験レビュー(2014年上半期)
■ 英文:Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2014
■ 発行日:2014年4月15日
■ 調査会社:GlobalData
■ 商品コード:GDHC2092CTIDB
■ 調査対象地域:グローバル
  • 培養乳製品の世界市場展望2017-20276
    According to Stratistics MRC, the Global Cultured Dairy Products market to grow at a CAGR of 8.7% during the forecast period. Some of the key factors influencing the market are new product launches and gaining prominence towards organic food and beverage products to the numerous health benefits. However, recall of products over various issues devices hampers the market growth of cultured dairy pro …
  • 実験室情報管理システム(LIMS)の世界市場2015-2019
    About LIMS LIMS is the information management system specifically designed for medical and industrial-related laboratories. The solution helps scientists in tracking samples and transmitting data to professionals. LIMS offers a way of automating the laboratory, and saves time and improves the quality of data. Benefits of using LIMS are: • Enhancement in efficiency of business • Improvement in qual …
  • 世界のゼロ・カロリー甘味料市場動向(2014~2018)
    TechNavio's analysts forecast the Global Zero-calorie Sweetener market to grow at a CAGR of 4.69 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing health-consciousness across the world. The Global Zero-calorie Sweetener market has also been witnessing the rise in consumer income levels in emerging countries. However, the negative criticisms …
  • Rosetta Resources Inc.:石油・ガスバリューチェーン分析レポート2013
    Rosetta Resources Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Rosetta Resources Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Rosetta Resources Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The repor …
  • 世界のビタミン及びプロビタミン市場(~2019)
    The expansion of the global vitamin and provitamin industry is forecast to reach 1.9% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 4.0%. Currently, dosage vitamins account for 25.8% of the global demand while the remaining market share is divided between intermixtures of vitamins and vitamin concentrates (4.2%), unmixed vitamin A (4.3%), unm …
  • 個人および在宅医療部門におけるロボットの世界市場2018-2022
    About robotics in personal and homecare sector Robotics market in personal and homecare sector consist of companion and emotional therapy robots, that support end-user by offering entertainment and companionship. Technavio’s analysts forecast the Global robotics market in personal and homecare sector to grow at a CAGR of 77.18% during the period 2018-2022. Covered in this report The report covers …
  • Myelofibrosis:グローバル臨床試験レビューH2, 2013
    Myelofibrosis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H2, 2013" provides data on the Myelofibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myelofibrosis. It includes an overview of the trial numbers and their recruitment status as per the …
  • ヨーロッパのDIY市場2016-2020
    About the DIY Market in Europe Do-it-yourself, also known as DIY, is a process of building, modifying, or repairing without the direct help of experts or professionals. DIY behavior can be triggered by the need for customization, lack of product availability and quality, and the prospect of economic benefits. DIY home improvement activities such as painting, assembling furniture, and landscaping a …
  • 高純度アルミナの世界市場2016-2020
    About Alumina Alumina, commonly known as Al2O3, is primarily used as a feedstock for the fabrication of metallic aluminum, known as smelter grade alumina (SGA). Approximately 90% of alumina is used in aluminum fabrication, and the remaining 10% is dedicated to the non-metallurgical market for industrial use. High-purity alumina, which characterizes alumina with a minimum purity of 99.99%, is the h …
  • モバイルコマース市場におけるグーグル(Google in Mobile Commerce)
    Despite its tremendous promise, m-commerce is facing significant acceptance barriers, which are caused largely in part by user interface restrictions of mobile devices. Generally, mobile users find it inconvenient to scroll through large amounts of information using a small screen and often inconvenient keypads. Google is determined to provide superior solutions in the Mobile commerce market. Part …
  • 開放角緑内障:世界の治験レビュー(2015年上半期版)
    Open-Angle Glaucoma Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Open-Angle Glaucoma Global Clinical Trials Review, H1, 2015" provides an overview of Open-Angle Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Open-Angle Glaucoma. Report includes an overview of trial numbers and their average enrollment …
  • 紙・板紙容器及びパッケージングの世界市場2019-2023
    Global Paper and Paperboard Container and Packaging Market: About this market Technavio’s paper and paperboard container and packaging market analysis considers sales from paper bags and sacks, corrugated containers and packaging, folding boxes and cases, and others. Our analysis also considers the sales of paper and paperboard container and packaging in APAC, Europe, North America, South America, …
  • 軍用機アクチュエータの世界市場2016-2020
    About the Military Aircraft Actuation Systems Market Actuation systems form an integral part of military aircraft, controlling a broad range of applications. Almost every movable part has an actuator, which performs various functions such as extension and retraction of landing gears, monitoring and controlling velocity, and controlling engine speed by adjusting levers and flaps. These systems are …
  • 世界のクライアント仮想化ソフトウェア市場動向(2014-2018)
    TechNavio's analysts forecast the Global Client Virtualization Software market to grow at a CAGR of 46.12 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing need for OS migration. The Global Client Virtualization Software market has also been witnessing the increase in cloud computing and cloud integration. However, the high deployment co …
  • 世界主要国における感染症検査市場2015
    This 155-page report provides detailed analyses of current and emerging technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scaltering, chromatography and several others. The report also presents strategic assessments of leading market play …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。